Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere.
Krohn, A., Redshaw, S., Ritchie, J.C., Graves, B.J., Hatada, M.H.(1991) J Med Chem 34: 3340-3342
- PubMed: 1956054 
- DOI: https://doi.org/10.1021/jm00115a028
- Primary Citation of Related Structures:  
1HXB
Organizational Affiliation: 
Roche Products Ltd., Welwyn Garden City, Hertfordshire, United Kingdom.